Gariépy J - Search Results

1

A stable human p53 heterotetramer based on constructive charge interactions within the tetramerization domain.

Brokx RD, Bolewska-Pedyczak E, Gariépy J. Brokx RD, et al. Among authors: gariepy j. J Biol Chem. 2003 Jan 24;278(4):2327-32. doi: 10.1074/jbc.M208528200. Epub 2002 Nov 13. J Biol Chem. 2003. PMID: 12433927 Free article.

2

Tandem dimerization of the human p53 tetramerization domain stabilizes a primary dimer intermediate and dramatically enhances its oligomeric stability.

Poon GM, Brokx RD, Sung M, Gariépy J. Poon GM, et al. Among authors: gariepy j. J Mol Biol. 2007 Jan 26;365(4):1217-31. doi: 10.1016/j.jmb.2006.10.051. Epub 2006 Oct 21. J Mol Biol. 2007. PMID: 17113101

3

Designing peptide-based scaffolds as drug delivery vehicles.

Brokx RD, Bisland SK, Gariépy J. Brokx RD, et al. Among authors: gariepy j. J Control Release. 2002 Jan 17;78(1-3):115-23. doi: 10.1016/s0168-3659(01)00491-6. J Control Release. 2002. PMID: 11772453

4

A simple two-step approach for introducing a protected diaminedithiol chelator during solid-phase assembly of peptides.

Gariépy J, Rémy S, Zhang X, Ballinger JR, Bolewska-Pedyczak E, Rauth M, Bisland SK. Gariépy J, et al. Bioconjug Chem. 2002 May-Jun;13(3):679-84. doi: 10.1021/bc0100814. Bioconjug Chem. 2002. PMID: 12009962

5

Nuclear magnetic resonance-based dissection of a glycosyltransferase specificity for the mucin MUC1 tandem repeat.

Brokx RD, Revers L, Zhang Q, Yang S, Mal TK, Ikura M, Gariépy J. Brokx RD, et al. Among authors: gariepy j. Biochemistry. 2003 Dec 2;42(47):13817-25. doi: 10.1021/bi0353070. Biochemistry. 2003. PMID: 14636048

6

Peptide- and polymer-based gene delivery vehicles.

Brokx R, Gariépy J. Brokx R, et al. Among authors: gariepy j. Methods Mol Med. 2004;90:139-60. doi: 10.1385/1-59259-429-8:139. Methods Mol Med. 2004. PMID: 14657563 Review. No abstract available.

7

Probing the impact of valency on the routing of arginine-rich peptides into eukaryotic cells.

Kawamura KS, Sung M, Bolewska-Pedyczak E, Gariépy J. Kawamura KS, et al. Among authors: gariepy j. Biochemistry. 2006 Jan 31;45(4):1116-27. doi: 10.1021/bi051338e. Biochemistry. 2006. PMID: 16430208

8

Charged and hydrophobic surfaces on the a chain of shiga-like toxin 1 recognize the C-terminal domain of ribosomal stalk proteins.

McCluskey AJ, Bolewska-Pedyczak E, Jarvik N, Chen G, Sidhu SS, Gariépy J. McCluskey AJ, et al. Among authors: gariepy j. PLoS One. 2012;7(2):e31191. doi: 10.1371/journal.pone.0031191. Epub 2012 Feb 15. PLoS One. 2012. PMID: 22355345 Free PMC article.

9

The carcinoembryonic antigen IgV-like N domain plays a critical role in the implantation of metastatic tumor cells.

Abdul-Wahid A, Huang EH, Cydzik M, Bolewska-Pedyczak E, Gariépy J. Abdul-Wahid A, et al. Among authors: gariepy j. Mol Oncol. 2014 Mar;8(2):337-50. doi: 10.1016/j.molonc.2013.12.002. Epub 2013 Dec 17. Mol Oncol. 2014. PMID: 24388361 Free PMC article.

10

The catalytic subunit of shiga-like toxin 1 interacts with ribosomal stalk proteins and is inhibited by their conserved C-terminal domain.

McCluskey AJ, Poon GM, Bolewska-Pedyczak E, Srikumar T, Jeram SM, Raught B, Gariépy J. McCluskey AJ, et al. Among authors: gariepy j. J Mol Biol. 2008 Apr 25;378(2):375-86. doi: 10.1016/j.jmb.2008.02.014. Epub 2008 Feb 15. J Mol Biol. 2008. PMID: 18358491

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters